Immunothérapie par anti-PD1 et carcinomes épidermoïdes cutanés localement avancés : un futur proche ? by Degache, E., Crochet, J., Simon, N., Tardieu, M., Trabelsi Messai, S., Moncourier, M., Templier, I., Benamar, K., Claeys, A., Leccia, M.-T., Foroni, L., Lemoigne, A., Pinel, N., Gil, H., Bouillet, L., Charles, J.

Get full text

Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta... by Salem, Atef, Ben Maaoui, Khouloud, Jahrami, Haithem, AlMarzooqi, Mezna A., Boukhris, Omar, Messai, Balsam, Clark, Cain C. T., Glenn, Jordan M., Ghazzaoui, Hadeel A., Bragazzi, Nicola Luigi, Ammar, Achraf, Trabelsi, Khaled, Chtourou, Hamdi

Get full text

High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma by Rischin, Danny, Hughes, Brett G M, Basset-Séguin, Nicole, Schadendorf, Dirk, Bowyer, Samantha, Trabelsi Messai, Sabiha, Meier, Friedegund, Eigentler, Thomas K, Casado Echarren, Victoria, Stein, Brian, Beylot-Barry, Marie, Dalac, Sophie, Dréno, Brigitte, Migden, Michael R, Hauschild, Axel, Schmults, Chrysalyne D, Lim, Annette M, Yoo, Suk-Young, Paccaly, Anne J, Papachristos, Apostolos, Nguyen, Jenny-Hoa, Okoye, Emmanuel, Seebach, Frank, Booth, Jocelyn, Lowy, Israel, Fury, Matthew G, Guminski, Alexander

Get full text